Results 201 to 206 of about 80,955 (206)
Some of the next articles are maybe not open access.
Rucaparib: An emerging parp inhibitor for treatment of recurrent ovarian cancer
Cancer Treatment Reviews, 2018Angela Musella +2 more
exaly
Rucaparib: An emerging parp inhibitor for treatment of recurrent ovarian cancer
Cancer Treatment Reviews, 2018